Brand Institute, the global leader in pharmaceutical and healthcare-related brand name and identity development, is pleased to share that Denmark-based Bavarian Nordic’s smallpox and monkeypox vaccine, named JYNNEOS®, was selected by TIME Magazine as one of the best inventions of 2022.

The National Institutes of Health said on Thursday it had started enrollments in a trial testing an alternative method of administering Bavarian Nordic’s monkeypox vaccine, Jynneos, which requires smaller dosages.

The European Union said on Wednesday it had secured an additional 170,920 doses of the monkeypox vaccine developed by biotech firm Bavarian Nordic amid concerns about the outbreak of the disease.

The U.S. Department of Health and Human Services (HHS) on Tuesday said it will significantly expand the number of distribution locations for monkeypox vaccines and treatments through a new $20 million contract with AmerisourceBergen Corp.

New infections with monkeypox are steadily declining in Spain, which has recorded the world’s second-highest tally of cases in this year’s global outbreak, Health Minister Carolina Darias said on Monday.

It is possible to eliminate the monkeypox outbreak in Europe, World Health Organization officials said on Tuesday, highlighting evidence that case counts are slowing in a handful of countries.

The U.S. government said on Monday it would provide about $11 million to support the packaging of Bavarian Nordic’s Jynneos monkeypox vaccine at a U.S.-based manufacturer’s facility.

Monkeypox cases in some large U.S. cities appear to be declining, matching trends seen in Europe, and experts are cautiously optimistic the outbreak may have peaked in places hit hardest hit by the virus.

Bavarian Nordic, the maker of the only approved monkeypox vaccine, said on Wednesday it was exploring the viability of using technically expired doses to help bridge a growing gap between demand and supply due to the current outbreak.

Switzerland plans to procure 40,000 doses of monkeypox vaccine as well as 500 units of an antiviral drug, the government said on Wednesday.